October 2017 - Page 4 of 20

Why You Should Keep an Eye on Trans Global Group, Inc.

Trans Global Group, Inc. (OTC:$TGGI) is gaining attention from investors after it proposed a new growth strategy, including marijuana licenses in a process from multiple states. Specifically, TGG trumpets itself as a company, through its ... [Read]

Call Dates and 3rd Quarter Earnings Set by Ashford Hospitality Trust

Oct 24 Dylan Bernhardt

It was announced that Ashford Hospitality Hospitality Trust (NYSE:$AHT) has set dates for its 3rd quarter. Its 3rd quarter ended on September 30, 2017. The report will be officially released by Ashford Trust when the ... [Read]

2017 Saskatchewan Top 100 Recognizes Cervus Equipment Corp

Oct 24 Dylan Bernhardt

In their 2017 Saskatchewan Top 100, SaskBusiness recognized Cervus Equipment Corp. (TSXV:CERV). The list was published in the September edition of SaskBusiness, and contained a list of the top 100 most prominent business organizations from ... [Read]

SunPower Corporation Registers a 2.84% Price Change After Morning Session

Oct 24 Jen Jiang

As of morning trading, SunPower Corporation (NASDAQ:$SPWR) stock saw a move of 2.84% with the closing price of $6.87. During the past week, the company saw a total shift of 1.93%. Over the last three ... [Read]

Head-to-Head: Axcelis Technologies VS Xcerra Corporation

Oct 24 Dylan Bernhardt

When it comes to small-cap computer technology companies, Xcerra Corporation (NASDAQ:$XCRA) and Axcelis Technologies (NASDAQ:$ACLS) are two contenders. How do they stack up against each other, though? Let’s look at the stats of these two ... [Read]

3D Signatures Announces Successful Clinical Trial Completion in New Lymphoma Drug

Oct 24 Jen Jiang

3D Signatures, Inc. (TSXV:DXD) officially announced that the company had completed the clinical trial component, or Stage 3, of its Hodgkin’s lymphoma test validation program. Data from the clinical trial has been further submitted to ... [Read]

Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter

Oct 24 Jen Jiang

According to the Zacks Investment Research report, Equities analysts forecast that Imperva, Inc. (NYSE:$IMPV) will see sales of $83.07 million for the current quarter. Seven analysts have issued estimates for Imperva’s earnings. The lowest sales ... [Read]

Head-to-Head: Impax Laboratories VS. SCYNEXIS

Oct 24 Dylan Bernhardt

Impax Laboratories (NASDAQ:$IPXL) and SCYNEXIS (NASDAQ:$SCYX) are both small-cap companies competing in the medical sector. So how do these two rivals stack up against each other? Let’s look at the numbers. Profitability Impax Laboratories has ... [Read]

Snapdragon 660 Mobile Platform To Be Included in New Intrinsyc Hardware Development Kit

Oct 24 Dylan Bernhardt

On Monday, Intrinsyc Technologies Corporation (TSXV:ITC), announced that it was releasing a new Hardware Development Kit featuring the Qualcomm (NASDAQ:$QCOM) Snapdragon 660 Mobile Platform. Intrinsyc is a leading developer of intelligent connected devices. Intrinsyc also ... [Read]

Anavex Life Sciences Corp.: Top Holders Statistics

Oct 23 Jen Jiang

Anavex Life Sciences Corp. (NASDAQ:$AVXL) reached 75.36% versus a 1-year low price of $2.76. On October 20th, the stock was last seen 3.64% higher, reaching at $4.84. At the most recent session, Anavex shares are ... [Read]